These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20486826)

  • 1. Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome.
    Marinangeli CP; Jones PJ
    Ann Med; 2010 Jul; 42(5):317-33. PubMed ID: 20486826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia.
    Marinangeli CP; Jones PJ
    Nutr Metab (Lond); 2010 Sep; 7():76. PubMed ID: 20920192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-nutrient interactions in the metabolic syndrome.
    Phillips CM; Tierney AC; Roche HM
    J Nutrigenet Nutrigenomics; 2008; 1(3):136-51. PubMed ID: 19776623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary management of the metabolic syndrome beyond macronutrients.
    Minich DM; Bland JS
    Nutr Rev; 2008 Aug; 66(8):429-44. PubMed ID: 18667004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study.
    Hosseini-Esfahani F; Jessri M; Mirmiran P; Bastan S; Azizi F
    Metabolism; 2010 Dec; 59(12):1833-42. PubMed ID: 20667561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gazing into the crystal ball: future considerations for ensuring sustained growth of the functional food and nutraceutical marketplace.
    Marinangeli CP; Jones PJ
    Nutr Res Rev; 2013 Jun; 26(1):12-21. PubMed ID: 23561318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersize teens: the metabolic syndrome.
    Ornstein RM; Jacobson MS
    Adolesc Med Clin; 2006 Oct; 17(3):565-87; abstract x. PubMed ID: 17030280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutraceuticals and prevention of atherosclerosis: focus on omega-3 polyunsaturated fatty acids and Mediterranean diet polyphenols.
    Massaro M; Scoditti E; Carluccio MA; De Caterina R
    Cardiovasc Ther; 2010 Aug; 28(4):e13-9. PubMed ID: 20633019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbals used for diabetes, obesity, and metabolic syndrome.
    Najm W; Lie D
    Prim Care; 2010 Jun; 37(2):237-54. PubMed ID: 20493334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
    Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
    Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting vascular risk in patients with metabolic syndrome but without diabetes.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Didangelos TP; Peletidou A; Kleta D; Karagiannis A; Kakafika AI; Tziomalos K; Elisaf M
    Metabolism; 2005 Aug; 54(8):1065-74. PubMed ID: 16092057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.
    Grundy SM
    Nat Rev Drug Discov; 2006 Apr; 5(4):295-309. PubMed ID: 16582875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional support in the pharmacological treatment of metabolic syndrome.
    Visioli F
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S43-9. PubMed ID: 21813086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
    Ginsberg HN; Stalenhoef AF
    J Cardiovasc Risk; 2003 Apr; 10(2):121-8. PubMed ID: 12668909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.